Newron Pharmaceuticals SpA banner

Newron Pharmaceuticals SpA
SIX:NWRN

Watchlist Manager
Newron Pharmaceuticals SpA Logo
Newron Pharmaceuticals SpA
SIX:NWRN
Watchlist
Price: 18.3 CHF -2.03% Market Closed
Market Cap: CHf366.2m

Intrinsic Value

The intrinsic value of one NWRN stock under the Base Case scenario is 10.09 CHF. Compared to the current market price of 18.3 CHF, Newron Pharmaceuticals SpA is Overvalued by 45%.

NWRN Intrinsic Value
10.09 CHF
Overvaluation 45%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Newron Pharmaceuticals SpA

What is Valuation History?
Ask AI Assistant
What other research platforms think about NWRN?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is NWRN valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Newron Pharmaceuticals SpA.

Explain Valuation
Alternatives to NWRN

Fundamental Analysis

Financials
Efficiency

Earnings Waterfall
Newron Pharmaceuticals SpA

Wall St
Price Targets

Dividends

Newron Pharmaceuticals SpA
does not pay dividends
Shareholder Yield

Competitive Landscape

What is the Intrinsic Value of one NWRN stock?

The intrinsic value of one NWRN stock under the Base Case scenario is 10.09 CHF.

Is NWRN stock undervalued or overvalued?

Compared to the current market price of 18.3 CHF, Newron Pharmaceuticals SpA is Overvalued by 45%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett